A joint statement of the World Federation of Hemophilia (WFH), European Haemophilia Consortium (EHC) and National Hemophilia Foundation (NHF) November 6, 2020 – The WFH,...
Takeda has suspended screening and further enrollment in the clinical studies of its AAV8 gene therapies for the treatment of hemophilia A and B. The...
In a letter to the global hemophilia community, Roche describes its plan for keeping healthcare professionals and patients informed of new efficacy and safety data...
Roche and Genentech have announced an update on measures being taken in relation to the translucent silicon oil and protein particles that were identified in...
After much anticipation, the World Federation of Hemophilia (WFH) World Bleeding Disorders Registry (WBDR) 2019 Data Report has been published. This is the second edition...